Chitosan

Chitosan
Product Description

Reproducible Biomedical Chitosan

LAGOSTA SA

  • CH
  • 2023
    On CPHI since
Company types
Biopharmaceutical company
Other
Specifications
  • Details
    EMA pharmacopeia and US monograph - Produced in GMP like conditions
  • Selling Points
    Product Features; Batch to batch reproducibilityExceeding regulatory requirements
    Long term sourcing for clinical trials and go to market
    65x lower carbon footprint
  • Supplied from
    Monaco

LAGOSTA SA

  • CH
  • 2023
    On CPHI since
Company types
Biopharmaceutical company
Other